Posted on 8/26/20
Delta Dental Community Care Foundation Awards More Than $2 Million in Grants to New York Nonprofits
The Delta Dental Community Care Foundation has given grants to 19 organizations, totaling more than $2 million, in New York to provide relief amid the COVID-19 . . .
Posted on 8/26/20
Phosplatin Therapeutics Completes $18.4 Million Private Financing Round
Phosplatin Therapeutics LLC, a clinical stage pharmaceutical company focused on oncology therapeutics, today announced the completion of an oversubscribed $18.4 million private financing round. Participation included . . .
Posted on 8/26/20
MetLife Investment Management Originates $6.2 Billion in Private Placement Debt For 1H 2020
WHIPPANY, N.J.--(BUSINESS WIRE)--MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE: MET), today announced it originated $6.2 billion in private placement debt . . .
Posted on 8/25/20
Otsuka America Pharmaceutical Purchases the Assets of Proteus Digital Health
PRINCETON, N.J.--(BUSINESS WIRE)--Otsuka America Pharmaceutical, Inc., (Otsuka) today announces that it has purchased the assets of Proteus Digital Health, Inc., including assets and intellectual property for . . .
Posted on 8/25/20
Modern Healthcare Names VirtualHealth a 2020 Best Place to Work in Healthcare
NEW YORK--(BUSINESS WIRE)--VirtualHealth, provider of HELIOS, the leading SaaS care management platform, has been named as one of 2020’s ”Best Places to Work in Healthcare” by . . .
Posted on 8/25/20
ContraFect Announces Funding Agreement with the Cystic Fibrosis Foundation
YONKERS, New York, Aug. 25, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents . . .
Posted on 8/24/20
NanoVibronix Announces $2.5M Bought Deal Offering
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, announced . . .
Posted on 8/24/20
Northern Westchester Hospital Appoints Ann Kenyon to Board of Overseers
Ann M. Kenyon, a CPA and retired senior partner at Deloitte with more than 35 years of experience, has been named
Posted on 8/24/20
Glens Falls Hospital and aptihealth Announce Partnership
Glens Falls Hospital and aptihealth, the leader in intelligent integrated behavioral healthcare, today announced a groundbreaking partnership to deliver rapid access to virtual care. In providing . . .
Posted on 8/24/20
Catalent Signs Agreement with AstraZeneca
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and . . .
Posted on 8/24/20
Yumanity Therapeutics and Proteostasis Therapeutics Merge
Yumanity Therapeutics and Proteostasis Therapeutics, Inc. (Nasdaq: PTI) today announced that the companies have entered into a definitive merger agreement.
Posted on 8/24/20
Pfizer and BioNTech's Coronavirus Vaccine Candidate Produces Antibodies in People Up to 85 Years Old
If a vaccine does its job, it will produce a strong immune response in the patients inoculated with it -- driving the body to make antibodies . . .
Posted on 8/23/20
Royalty Pharma Announces Launch of Senior Notes Offering
NEW YORK (GLOBE NEWSWIRE) -- Royalty Pharma plc announced today that it intends to offer, subject to market and other conditions, senior unsecured notes in multiple . . .
Posted on 8/23/20
Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders
CRANFORD, N.J., Aug. 21, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTC: ENZN) today announced that its Board of Directors (the “Board”) has approved a rights offering . . .
Posted on 8/23/20
Eyenovia Proposes Public Offering of Common Stock
NEW YORK, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) . . .
Posted on 8/21/20
DSS Completes Impact BioMedical Acquisition
ROCHESTER, N.Y., Aug. 21, 2020 (GLOBE NEWSWIRE) -- Document Security Systems, Inc. (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, . . .
Posted on 8/21/20
Why Is Everyone Talking About Pfizer?
If you follow stock market news, chances are you have come across plenty of stories about Pfizer (NYSE:PFE) over the past three months. Pfizer is one . . .
Posted on 8/21/20
Johnson & Johnson to Launch Late-Stage Coronavirus Vaccine Trials in September
Might Johnson & Johnson (NYSE:JNJ) soon vault to the top of the coronavirus stock list?It's conceivable, as an entry on the government's list of clinical trials . . .
Posted on 8/20/20
Garwood Medical Devices Announces Series C Funding
Garwood Medical Devices, a leader in groundbreaking medical device technology, today announced a Series C financing round of $4 million to support additional preclinical testing for . . .
Posted on 8/20/20
Pivot Health Announces Partnership With Quotit Corporation
NEW YORK--(BUSINESS WIRE)--Pivot Health, a division of HealthCare.com, a leader in technology-enabled health insurance solutions, today announced its partnership with Quotit Corporation, an insurance software service . . .
Posted on 8/20/20
MetLife Announces Alliance With Barnum Financial Group
NEW YORK--(BUSINESS WIRE)--MetLife announced today that Barnum Financial Group, a financial planning and wealth management firm headquartered in Connecticut, will lead the nationwide delivery of MetLife’s . . .
Posted on 8/20/20
Regeneron and Roche Team Up to Triple Production of COVID-19 Treatment
Regeneron's (NASDAQ:REGN) COVID-19 treatment candidate is getting a big boost from Roche (OTC:RHHB.Y). The two companies announced in a joint press release Wednesday that they are . . .
Posted on 8/19/20
Johnson & Johnson to Acquire Momenta Pharmaceuticals for $6.5B
Johnson & Johnson (NYSE:JNJ) today announced it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc., a company that discovers and develops novel therapies
Posted on 8/19/20
J&J To Acquire Momenta Pharmaceuticals For $6.5B
Johnson & Johnson (NYSE:JNJ) has agreed to acquire Momenta Pharmaceuticals (NASDAQ:MNTA) for $52.50 per share in cash for a total of $6.5B.
Posted on 8/18/20
Northern Westchester Hospital First in New York State to Use Magtrace Dye
Northern Westchester Hospital (NWH) is the first hospital in New York State to use a non-radioactive guidance system to locate and remove tumors in patients with . . .
New York
